BerandaCRL • NYSE
add
Charles River Lbrtrs ntrntl Inc
$223,15
Setelah Jam Perdagangan Normal:(0,00%)0,00
$223,15
Tutup: 17 Jul, 16.09.05 GMT-4 · USD · NYSE · Pernyataan Penyangkalan
Tutup sebelumnya
$227,31
Rentang hari
$223,03 - $231,39
Rentang tahun
$161,65 - $275,00
Kapitalisasi pasar
11,49 M USD
Volume Rata-Rata
476,73 rb
Rasio P/E
26,18
Hasil dividen
-
Bursa utama
NYSE
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
(USD) | Mar 2024info | Perubahan Y/Y |
---|---|---|
Pendapatan | 1,01 M | -1,73% |
Biaya operasional | 209,59 jt | 0,46% |
Laba bersih | 72,96 jt | -29,26% |
Margin laba bersih | 7,21 | -28,04% |
Penghasilan per saham | 2,27 | -18,35% |
EBITDA | 228,53 jt | -8,31% |
Tarif pajak efektif | 24,77% | — |
Neraca
Total aset
Total liabilitas
(USD) | Mar 2024info | Perubahan Y/Y |
---|---|---|
Investasi tunai jangka pdk | 327,04 jt | 62,23% |
Total aset | 8,15 M | 5,89% |
Total liabilitas | 4,45 M | -2,06% |
Total ekuitas | 3,70 M | — |
Saham yang beredar | 51,51 jt | — |
Harga terhadap reservasi | 3,22 | — |
Tingkat pengembalian aset | 4,38% | — |
Pengembalian modal | 5,27% | — |
Arus Kas
Perubahan bersih tunai
(USD) | Mar 2024info | Perubahan Y/Y |
---|---|---|
Laba bersih | 72,96 jt | -29,26% |
Kas dari operasi | 129,89 jt | 18,75% |
Tunai dari investasi | -85,79 jt | 49,12% |
Tunai dari pembiayaan | 18,35 jt | -27,32% |
Perubahan bersih tunai | 54,06 jt | 267,23% |
Arus kas bebas | 38,88 jt | 200,52% |
Tentang
Charles River Laboratories International, Inc., is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services for the pharmaceutical, medical device and biotechnology industries. It also supplies assorted biomedical products, outsourcing services, and animals for research and development in the pharmaceutical industry and offers support in the fields of basic research, drug discovery, safety and efficacy, clinical support, and manufacturing.
According to the company, it supported the development of approximately 85% of novel FDA-approved drugs in 2021.
Its customers include leading pharmaceutical, biotechnology, agrochemical, government, and academic organization around the globe. The company has over 90 facilities, operates in 20 countries, and employs approximately 18,400 people worldwide.
Charles River Laboratories is often criticized by animal rights activists who condemn the company's usage of dogs and non-human primates for pharmaceutical purposes. The company is also a major harvester of horseshoe crab blood. Wikipedia
Didirikan
1947
Kantor pusat
Situs
Karyawan
21.100